XML 45 R28.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE CAPITAL (Tables)
12 Months Ended
Dec. 31, 2022
SHARE CAPITAL  
Summary of Stock Option Activity

a)

Options granted to employees and directors:

​

​

​

​

​

​

​

​

​

Year Ended December 31, 2022

​

    

​

    

Weighted

​

​

Number

​

average

​

​

of

​

exercise

​

​

options

​

price

Outstanding at beginning of year

 

2,259,020

​

$

4.42

Changes during the year:

 

  

​

 

  

Granted

 

3,480,000

​

 

1.03

Forfeited and expired

 

219,705

​

 

4.62

Outstanding at end of year

 

5,519,315

​

$

2.28

Exercisable at end of year

 

1,731,434

​

$

4.25

​

Summary of Restricted Stock Activity

​

​

​

​

​

​

​

Year Ended December 31, 2022

​

​

​

Number of Restricted Stock

​

Outstanding at beginning of year

​

458,027

​

Changes during the year:

​

​

​

Granted

​

759,482

​

Vested

​

926,035

​

Non vested at end of year

​

291,474

​

Summary of Share Options Outstanding and Exercisable

​

​

​

​

​

​

​

​

​

​

​

December 31, 2022

​

​

Options outstanding

​

Options exercisable

​

    

Number of

    

Weighted

    

​

    

Weighted

​

​

options 

​

average

​

​

​

average

​

​

outstanding

​

remaining

​

Number of

​

remaining

Exercise

​

at end of

​

contractual

​

options

​

contractual

prices

​

year

​

life

​

exercisable

​

life

$1.03-$2.00

​

3,610,000

​

9.60

​

300,625

​

8.99

$3.55-$3.73

​

1,361,965

​

6.78

​

903,459

​

6.48

$4.69-$5.60

 

466,000

 

5.71

 

446,000

 

5.67

$17.20

 

81,350

 

2.10

 

81,350

 

2.10

​

 

5,519,315

​

​

 

1,731,434

​

​

Schedule of Stock Option Valuation Assumptions

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

​

​

​

2020

​

2021

​

2022

​

Stock price (USD)

​

3.64

​

1.57

​

1.03

​

Exercise price (USD)

​

3.64

​

1.57

 

1.03

​

Risk free rate

​

0.74

%

0.88

%

3.32

%

Volatility

​

79.50

%

84.30

%

85.94

%

Dividend yield

​

0

%

0

%

0

%

Expected life (Years)

​

6

​

6

​

6

​

Schedule of Stock-Based Compensation Expense in Statement of Operations

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

(U.S. dollars in thousands)

    

2020

    

2021

    

2022

Cost of goods sold

​

​

​

​

$

269

​

$

135

Research and development expenses

​

$

1,036

​

​

648

​

​

518

Selling, general and administrative expenses

​

 

2,090

​

 

1,458

​

 

1,432

​

​

$

3,126

​

$

2,375

​

$

2,085